Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies

Getie-Kebtie, 2013, Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines, Influenza Other Respir Viruses, 7, 521, 10.1111/irv.12001 Cohen, 2013, Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase, Virol J, 10, 321, 10.1186/1743-422X-10-321 Gomez Lorenzo, 2013, Immunobiology of influenza vaccines, Chest, 143, 502, 10.1378/chest.12-1711 WHO. WHO | Influenza (Seasonal). WHO (2016). Available at: http://www.who.int/mediacentre/factsheets/fs211/en/ [Accessed: 24th April 2017]. Krammer, 2018, NAction! How can neuraminidase-based immunity contribute to better influenza virus Vaccines?, mBio, 9, 10.1128/mBio.02332-17 Pica, 2013, Toward a universal influenza virus vaccine: prospects and challenges, Annu Rev Med, 64, 189, 10.1146/annurev-med-120611-145115 Manini, 2015, Flucelvax (Optaflu) for seasonal influenza, Expert Rev Vaccines, 14, 789, 10.1586/14760584.2015.1039520 Dunkle, 2017, Efficacy of recombinant influenza vaccine in adults 50 years of age or older, N Engl J Med, 376, 2427, 10.1056/NEJMoa1608862 López-Macías, 2011, Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico, Vaccine, 29, 7826, 10.1016/j.vaccine.2011.07.099 Mohsen, 2017, Major findings and recent advances in virus–like particle (VLP)-based vaccines, Semin Immunol, 34, 123, 10.1016/j.smim.2017.08.014 Hu, 2017, Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models, BMC Biotechnol, 17, 10.1186/s12896-016-0321-6 Wu, 2010, Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus, PLoS One, 5 Pillet, 2016, A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults, Clin Immunol, 168, 72, 10.1016/j.clim.2016.03.008 Tretyakova, 2016, Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein, Virology, 487, 163, 10.1016/j.virol.2015.10.007 Venereo-Sanchez, 2016, Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate, Vaccine, 34, 3371, 10.1016/j.vaccine.2016.04.089 Maegawa, 2018, Overexpression of a virus-like particle influenza vaccine in Eri silkworm pupae, using Autographa californica nuclear polyhedrosis virus and host-range expansion, Arch Virol, 163, 2787, 10.1007/s00705-018-3941-4 Cervera, 2018, Large-Scale Transient Transfection of Suspension Mammalian Cells for VLP Production, vol. 1674, 117 Venereo-Sanchez, 2017, Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line, Vaccine, 35, 4220, 10.1016/j.vaccine.2017.06.024 Venereo-Sánchez, 2019, Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF, Vaccine, 37, 7100, 10.1016/j.vaccine.2019.07.057 Gutiérrez-Granados, 2018, Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics, Crit Rev Biotechnol, 38, 918, 10.1080/07388551.2017.1419459 Bialas, 2012, Specific Residues in the 2009 H1N1 swine-origin influenza matrix protein influence virion morphology and efficiency of viral spread in vitro, PLoS One, 7, 10.1371/journal.pone.0050595 Cheng, 1997, A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak, Proc Natl Acad Sci USA, 94, 690, 10.1073/pnas.94.2.690 Medina, 2014, Vero/CHOK1, a novel mixture of cell lines that is optimal for the rescue of influenza A vaccine seeds, J Virol Methods, 196, 25, 10.1016/j.jviromet.2013.09.007 Stöhr, 2012, Influenza virus surveillance, vaccine strain selection, and manufacture, Influenza Virus, 147, 10.1007/978-1-61779-621-0_9 Gerber, 2003, Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS, Proc Natl Acad Sci, 100, 6940, 10.1073/pnas.0832254100 Williams, 2012, Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry, Vaccine, 30, 2475, 10.1016/j.vaccine.2011.12.056 MacLean, 2010, Skyline: an open source document editor for creating and analyzing targeted proteomics experiments, Bioinformatics, 26, 966, 10.1093/bioinformatics/btq054 E56 Committee. Guide for measurement of particle size distribution of nanomaterials in suspension by nanoparticle tracking analysis (NTA). ASTM International. https://doi.org/10.1520/E2834-12R18. Burlaud-Gaillard, 2014, Correlative scanning-transmission electron microscopy reveals that a chimeric Flavivirus Is Released as individual particles in secretory vesicles, PLoS One, 9, e93573, 10.1371/journal.pone.0093573 Pion, 2014, Characterization and immunogenicity in mice of recombinant influenza haemagglutinins produced in Leishmania tarentolae, Vaccine, 32, 5570, 10.1016/j.vaccine.2014.07.092 Ananthanarayan, 1960, Non-specific inhibitors of influenza viruses in normal sera, Bull World Health Organ, 22, 409 Couzens, 2014, An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera, J Virol Methods, 210, 7, 10.1016/j.jviromet.2014.09.003 Schanen, 2008, A novel approach for the generation of human dendritic cells from blood monocytes in the absence of exogenous factors, J Immunol Methods, 335, 53, 10.1016/j.jim.2008.02.021 Dauner, 2017, The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination, Vaccine, 35, 5487, 10.1016/j.vaccine.2017.03.099 Drake, 2012, In Vitro biomimetic model of the human immune system for predictive vaccine assessments, Disruptive Sci Technol, 1, 28, 10.1089/dst.2012.0006 Kramberger, 2012, Evaluation of nanoparticle tracking analysis for total virus particle determination, Virol J, 9, 265, 10.1186/1743-422X-9-265 Cotter, 2014, A Single amino acid in the stalk region of the h1n1pdm influenza virus HA protein affects viral fusion. Stability and Infectivity, PLOS Pathog, 10, e1003831, 10.1371/journal.ppat.1003831 Li, 2010, Cell culture processes for monoclonal antibody production, mAbs, 2, 466, 10.4161/mabs.2.5.12720 Hofmann, 2015, Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system, Biotechnol Bioeng, 112, 2505, 10.1002/bit.25670 Barrett, 2009, Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines, Expert Rev Vaccines, 8, 607, 10.1586/erv.09.19 Ehrlich, 2012, Clinical development of a Vero cell culture-derived seasonal influenza vaccine, Vaccine, 30, 4377, 10.1016/j.vaccine.2011.11.114 Cervera, 2013, Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium, J Biotechnol, 166, 152, 10.1016/j.jbiotec.2013.05.001 Garg, 2017, Development of virus-like-particle vaccine and reporter assay for Zika virus, J Virol, 91, 10.1128/JVI.00834-17 Lai, 2010, Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase, J Gen Virol, 91, 2322, 10.1099/vir.0.019935-0 Stepanenko, 2015, HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution, Gene, 569, 182, 10.1016/j.gene.2015.05.065 Chlanda, 2015, Structural analysis of the roles of influenza A virus membrane-associated proteins in assembly and morphology, J. Virol, 89, 8957, 10.1128/JVI.00592-15 Shaw, 2008, Cellular proteins in influenza virus particles, PLoS Pathog, 4, e1000085, 10.1371/journal.ppat.1000085 Vernay, 2019, Comparative analysis of the performance of residual host-cell DNA assays for viral vaccines produced in Vero cells, J Virol Methods, 10.1016/j.jviromet.2019.01.001 Thompson, 2015, Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems, BMC Biotechnol, 15, 10.1186/s12896-015-0152-x Couch, 2012, Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines, Vaccine, 31, 190, 10.1016/j.vaccine.2012.10.065 Rajendran, 2017, Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: evidence for original antigenic, Sin mBio, 8, e02281 Bodewes, 2010, Animal models for the preclinical evaluation of candidate influenza vaccines, Expert Rev Vaccines, 9, 59, 10.1586/erv.09.148